HSL Mobile App
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
TechnicalThe key levels help you plan your entry and exit point.
-
Profit & LossTake a quick look at the revenues and expenditure sheet.
-
Balance SheetIts a statement of assets, liabilities and share capital.
-
Dividend HistoryCheck out the detailed payout data over the last three years.
-
Comparative ReturnsReveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
-
-
Resistance 2
-
-
Support 1
-
-
Support 2
-
-
Moving Average
20 Days
-
-
50 Days
-
-
100 Days
-
-
200 Days
-
-
Growth in 3 years
Sales
Sales Industry Avg
PAT
PAT Industry Avg
Sales Industry Avg
PAT
PAT Industry Avg
Growth in 3 years
Total Asset Growth
26.45%
Total Liabilities growth
9.50%
Reserves Change
-6.41%
26.45%
Total Liabilities growth
9.50%
Reserves Change
-6.41%
Relative to Sensex rtn in 3 year
Relative to Nifty rtn in 3 year
Relative to top 3 MF rtn in 3 year
Relative to Nifty rtn in 3 year
Relative to top 3 MF rtn in 3 year
| 2016 | 2014 | 2014 | |
|---|---|---|---|
| Sales | 59.91 | 59.91 | 59.91 |
| Gross Profit | 60.14 | 60.14 | 60.14 |
| Operating Profit | 6.14 | 6.14 | 6.14 |
| Sales | 59.91 | 59.91 | 59.91 |
| Gross Profit | 60.14 | 60.14 | 60.14 |
| Operating Profit | 6.14 | 6.14 | 6.14 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made
investment of
in
Months Ago
with a
frequency
for
Months
in
My investment would be worth
with a
of
%
one电竞app投注
Stocks and sector-wise Research Reports by one电竞(新疆)在线登录 securities help you analyse, understand and take a informed investment decision.
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
Our Research Analysis
As of today
18.2 %
Target Achived
18.2 %
Target Achived
This call still has potential to give significant positive returns
Potential Upside
+22.8 %
Buy Call with 3 month time frame
+22.8 %
Buy Call with 3 month time frame
CMP :
1758
Target :
1658
Stop Loss :
1858
Reco Price :
1858
Call Type :
1858
Reco Date :
12/09/2016
Rationale
History
|
15
jan 2016 |
Call initiated
Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
|
15
jan 2016 |
Call initiated
Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
|
15
jan 2016 |
Call initiated
Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
As of today
__PERCENT__ %
Target Achived
__PERCENT__ %
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__ %
Buy Call with __TIMEFRAME__ time frame
CMP :
__CMP__
Target :
__TARGET__
Stop Loss :
__STOPLOSS__
Reco Price :
__RECOPRICE__
Reco Date :
__RECODATE__
Call Type :
__CALLTYPE__
__Rationale__
__RECOTYPE__
__COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated
Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View
__RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
__Name__
__LTP__
Chg:
__ChangePer__
Expiry Month __Date__
Day's Low
__DaysLow__
__DaysLow__
Day's High
__DaysHigh__
__DaysHigh__
Day’s Open
__DaysOpen__
__DaysOpen__
Prev Close
__PreviousClose__
__PreviousClose__
Volume
__Volume__
__Volume__
OI
__OI__
__OI__
OI Change (%)
__OIPer__
__OIPer__
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
| Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
| Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
| Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
| Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
News
Stay tuned to the latest developments and happenings in the company.
Natco Pharma to hold AGM
Natco Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2022.Powered by Capital Market -....
05 Sep 2022 11:28Outcome of board meeting of Natco Pharma
The Board of Natco Pharma at its meeting held on 02 September 2022 has approved the following:To sell the investment of 15% of shareholding in Join....
02 Sep 2022 12:52Natco Pharma receives USFDA tentative approval for Trabectedin for Injection
Natco Pharma announced that the U.S. Food and Drug Administration has granted tentative approval to its Abbreviated New Drug Application (ANDA) for Tr....
17 Aug 2022 18:54Natco Pharma consolidated net profit rises 327.20% in the June 2022 quarter
Net profit of Natco Pharma rose 327.20% to Rs 320.40 crore in the quarter ended June 2022 as against Rs 75.00 crore during the previous quarter ended ....
09 Aug 2022 15:33Natco Pharma reports consolidated net loss of Rs 50.50 crore in the March 2022 quarter
Net loss of Natco Pharma reported to Rs 50.50 crore in the quarter ended March 2022 as against net profit of Rs 53.00 crore during the previous quarte....
30 May 2022 16:51Natco Pharma consolidated net profit rises 28.23% in the December 2021 quarter
Net profit of Natco Pharma rose 28.23% to Rs 80.40 crore in the quarter ended December 2021 as against Rs 62.70 crore during the previous quarter ende....
15 Feb 2022 08:15__heading__
Published on __date__ at __time__
__description__
Corporate News
Subscribe for our
newsletter
newsletter
